CN101724625A - 一种用金磁微粒纯化总核酸的方法 - Google Patents
一种用金磁微粒纯化总核酸的方法 Download PDFInfo
- Publication number
- CN101724625A CN101724625A CN200910219125A CN200910219125A CN101724625A CN 101724625 A CN101724625 A CN 101724625A CN 200910219125 A CN200910219125 A CN 200910219125A CN 200910219125 A CN200910219125 A CN 200910219125A CN 101724625 A CN101724625 A CN 101724625A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- total nucleic
- gold
- magnetic particles
- purifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 80
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 80
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 78
- 238000000034 method Methods 0.000 title claims abstract description 62
- 239000006249 magnetic particle Substances 0.000 title claims abstract description 32
- 238000002156 mixing Methods 0.000 claims abstract description 20
- -1 nucleic acid compound Chemical class 0.000 claims abstract description 15
- 239000012148 binding buffer Substances 0.000 claims abstract description 13
- 239000006228 supernatant Substances 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 25
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 24
- 239000006166 lysate Substances 0.000 claims description 14
- 238000010494 dissociation reaction Methods 0.000 claims description 13
- 230000005593 dissociations Effects 0.000 claims description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 12
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 8
- 101710163270 Nuclease Proteins 0.000 claims description 6
- 239000011246 composite particle Substances 0.000 claims description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 6
- 229910003002 lithium salt Inorganic materials 0.000 claims description 6
- 159000000002 lithium salts Chemical class 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 102000016911 Deoxyribonucleases Human genes 0.000 claims description 5
- 108010053770 Deoxyribonucleases Proteins 0.000 claims description 5
- 230000002000 scavenging effect Effects 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 238000005336 cracking Methods 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 2
- 102000006382 Ribonucleases Human genes 0.000 claims description 2
- 108010083644 Ribonucleases Proteins 0.000 claims description 2
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 claims description 2
- 229910001626 barium chloride Inorganic materials 0.000 claims description 2
- 229940045511 barium chloride Drugs 0.000 claims description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 238000013016 damping Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical group SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 claims description 2
- WTFCBWXBJBYVOS-UHFFFAOYSA-L lithium;sodium;dichloride Chemical group [Li+].[Na+].[Cl-].[Cl-] WTFCBWXBJBYVOS-UHFFFAOYSA-L 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 abstract description 12
- 239000000523 sample Substances 0.000 abstract description 11
- 238000001821 nucleic acid purification Methods 0.000 abstract description 7
- 239000012472 biological sample Substances 0.000 abstract description 3
- 238000004140 cleaning Methods 0.000 abstract description 3
- 230000009471 action Effects 0.000 abstract description 2
- 238000007885 magnetic separation Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 abstract 4
- 230000002934 lysing effect Effects 0.000 abstract 2
- 238000005119 centrifugation Methods 0.000 abstract 1
- 239000003480 eluent Substances 0.000 abstract 1
- 238000001962 electrophoresis Methods 0.000 description 15
- 239000006148 magnetic separator Substances 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 10
- 230000008520 organization Effects 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000000746 purification Methods 0.000 description 7
- 239000002122 magnetic nanoparticle Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000005352 clarification Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003196 chaotropic effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 239000002853 nucleic acid probe Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229910001566 austenite Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000001216 nucleic acid method Methods 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 231100000004 severe toxicity Toxicity 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 229910006297 γ-Fe2O3 Inorganic materials 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910219125A CN101724625B (zh) | 2009-11-25 | 2009-11-25 | 一种用金磁微粒纯化总核酸的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910219125A CN101724625B (zh) | 2009-11-25 | 2009-11-25 | 一种用金磁微粒纯化总核酸的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101724625A true CN101724625A (zh) | 2010-06-09 |
CN101724625B CN101724625B (zh) | 2012-09-19 |
Family
ID=42446177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910219125A Active CN101724625B (zh) | 2009-11-25 | 2009-11-25 | 一种用金磁微粒纯化总核酸的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101724625B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102864139A (zh) * | 2012-09-11 | 2013-01-09 | 西安交通大学口腔医院 | 一种用于组织细胞基因组dna的核酸吸附快速分离方法 |
CN103952400A (zh) * | 2014-04-23 | 2014-07-30 | 西安金磁纳米生物技术有限公司 | 一种利用金磁微粒纯化动物微量组织中总核酸的方法 |
CN105524918A (zh) * | 2016-03-02 | 2016-04-27 | 四川农业大学 | 一种高通量提取园艺植物叶片基因组dna的方法 |
CN111073886A (zh) * | 2020-01-16 | 2020-04-28 | 中国农业科学院农业基因组研究所 | 一种基于超顺磁性纳米颗粒的dna提取吸附液、试剂盒以及dna提取方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101165183B (zh) * | 2006-10-19 | 2010-05-12 | 陕西西大北美基因股份有限公司 | 利用金磁微粒分离mRNA的方法 |
CN101165182B (zh) * | 2006-10-19 | 2010-05-12 | 陕西西大北美基因股份有限公司 | 用金磁微粒纯化dna的方法 |
-
2009
- 2009-11-25 CN CN200910219125A patent/CN101724625B/zh active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102864139A (zh) * | 2012-09-11 | 2013-01-09 | 西安交通大学口腔医院 | 一种用于组织细胞基因组dna的核酸吸附快速分离方法 |
CN103952400A (zh) * | 2014-04-23 | 2014-07-30 | 西安金磁纳米生物技术有限公司 | 一种利用金磁微粒纯化动物微量组织中总核酸的方法 |
CN105524918A (zh) * | 2016-03-02 | 2016-04-27 | 四川农业大学 | 一种高通量提取园艺植物叶片基因组dna的方法 |
CN105524918B (zh) * | 2016-03-02 | 2018-06-15 | 四川农业大学 | 一种高通量提取园艺植物叶片基因组dna的方法 |
CN111073886A (zh) * | 2020-01-16 | 2020-04-28 | 中国农业科学院农业基因组研究所 | 一种基于超顺磁性纳米颗粒的dna提取吸附液、试剂盒以及dna提取方法 |
CN111073886B (zh) * | 2020-01-16 | 2023-08-29 | 中国农业科学院农业基因组研究所 | 一种基于超顺磁性纳米颗粒的dna提取吸附液、试剂盒以及dna提取方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101724625B (zh) | 2012-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2082039B1 (en) | Methods and kit for isolating nucleic acids | |
JP4036625B2 (ja) | 二本鎖/単鎖核酸構造物の分離方法 | |
JP5702717B2 (ja) | 核酸を単離する方法 | |
EP2258845B1 (en) | Isolation and purification of nucleic acids | |
EP1748072A1 (en) | Hydroxysilane functionalized magnetic particles and nucleic acid separation method | |
CN101165182B (zh) | 用金磁微粒纯化dna的方法 | |
WO2016075701A2 (en) | A method for extraction of dna using naked magnetic nanoparticles | |
CN101724625B (zh) | 一种用金磁微粒纯化总核酸的方法 | |
CN102344921B (zh) | 一种用金磁微粒纯化植物组织基因组dna的方法 | |
CN109215998A (zh) | 改进磁性硅颗粒及其用于核酸纯化的方法 | |
CN113388610B (zh) | 一种磁珠法快速提取细菌质粒dna的试剂盒及提取方法 | |
US20160194684A1 (en) | Method for extracting and purifying nucleic acids and buffers used | |
JP4551568B2 (ja) | 常磁性粒子を用いた集細胞及びライセート清澄化 | |
CN101748116A (zh) | 磁性微粒大量提取dna的方法 | |
CN110452903A (zh) | 一种无酶法全核酸提取试剂盒 | |
JP2005052142A (ja) | Rna単離用の装置及び方法 | |
JP2005052142A5 (zh) | ||
JP5183905B2 (ja) | 担体、担体の製造方法、およびその利用 | |
JPH11155567A (ja) | 核酸精製用酸化ジルコニウム及び類縁化合物 | |
CN110387369A (zh) | 一种能够满足微量核酸生物样本提取纯化要求的试剂盒及其使用方法 | |
JP2005151975A (ja) | Rna単離用の方法と装置 | |
JPH1075784A (ja) | リボ核酸の単離方法 | |
CN111849964A (zh) | 一种提取精液基因组dna的试剂盒及方法 | |
CN114350649A (zh) | 一种核酸提取试剂盒及核酸提取方法 | |
CN108866042B (zh) | 一种微量rna的提取方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: XI'AN GOLDMAG NANOBIOTECH CO., LTD. Free format text: FORMER OWNER: SHAANXI BAIMEI GENE CO., LTD. Effective date: 20130718 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: SHAANXI BAIMEI GENE CO., LTD. Free format text: FORMER NAME: SHAANXI LIFEGEN CO., LTD. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 710069 XI'AN, SHAANXI PROVINCE TO: 710077 XI'AN, SHAANXI PROVINCE |
|
CP01 | Change in the name or title of a patent holder |
Address after: 710069 Shaanxi city of Xi'an province Taibai Road No. 229 Patentee after: SHAANXI LIFEGEN Co.,Ltd. Address before: 710069 Shaanxi city of Xi'an province Taibai Road No. 229 Patentee before: Shaanxi North American Gene Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130718 Address after: 710077, Shaanxi, Xi'an hi tech Zone, No. 85, No. 4, No. 2, modern enterprise center, 3 east side, 10402A Patentee after: XI'AN GOLDMAG NANOBIOTECH Co.,Ltd. Address before: 710069 Shaanxi city of Xi'an province Taibai Road No. 229 Patentee before: SHAANXI LIFEGEN Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for purifying total nucleic acid by using gold-magnetic particles Effective date of registration: 20190626 Granted publication date: 20120919 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN GOLDMAG NANOBIOTECH Co.,Ltd. Registration number: 2019990000614 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200811 Granted publication date: 20120919 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN GOLDMAG NANOBIOTECH Co.,Ltd. Registration number: 2019990000614 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method of purifying total nucleic acid with gold magnetic particles Effective date of registration: 20200909 Granted publication date: 20120919 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN GOLDMAG NANOBIOTECH Co.,Ltd. Registration number: Y2020990001085 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210903 Granted publication date: 20120919 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN GOLDMAG NANOBIOTECH Co.,Ltd. Registration number: Y2020990001085 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for purifying total nucleic acid with gold magnetic particles Effective date of registration: 20210903 Granted publication date: 20120919 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN GOLDMAG NANOBIOTECH Co.,Ltd. Registration number: Y2021990000806 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220906 Granted publication date: 20120919 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN GOLDMAG NANOBIOTECH Co.,Ltd. Registration number: Y2021990000806 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |